Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1/2 2Phase 1 2

Status

Completed 2

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other neoplasm 2Gastrointestinal 2Dermatologic 2Thoracic 1Sarcoma 1Head & Neck 1Gynecologic 1CNS 1Breast 1

Conditions

Stomach Neoplasms 1Rectal Neoplasms 1Liver Neoplasms 1Gallbladder Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Hepatocellular 1Bile Duct Neoplasms 1

Interventions

Gemcitabine 217Fluorouracil 141Oxaliplatin 131Capecitabine 122pembrolizumab 113Irinotecan 109Leucovorin 103Bevacizumab 98Nivolumab 80130-nm albumin-bound paclitaxel 80Cisplatin 79Cetuximab 79Radiotherapy 78Albumin-Bound Paclitaxel 59Sorafenib 56Paclitaxel 53Cyclophosphamide 49Carboplatin 47Magnetic Resonance Spectroscopy 43Specimen Handling 39Docetaxel 37Taxes 36Radiation 34fludarabine 33Ipilimumab 33Erlotinib Hydrochloride 33durvalumab 32Biopsy 32Folfox protocol 28Radiosurgery 27

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Microarray Analysis × Gastrointestinal × Clear all
NCT00486356 2024-01-03

Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer

University of Nebraska

Phase 1 Completed
46 enrolled
Gastrointestinal

Bile Duct Neoplasms, Gallbladder Neoplasms, Carcinoma, Hepatocellular, Liver Neoplasms, Stomach Neoplasms

NCT00611000 2009-02-17

Effect of Folate on DNA in Colon Tissue and Blood Samples From Patients at Increased Risk of Developing Colorectal Neoplasia

National Cancer Institute (NCI)

Phase 1 Completed
20 enrolled
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡